-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$12.00-42.86% Downside
ZIVO Bioscience, Inc. Frequently Asked Questions
-
What analysts cover ZIVO Bioscience, Inc.?
ZIVO Bioscience, Inc. has been rated by research analysts at Maxim Group in the past 90 days.